HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,090,051 | +16.0% | 36,732 | -10.2% | 0.43% | -1.6% |
| Q2 2022 | $1,801,000 | +17.8% | 40,923 | +11.6% | 0.44% | +91.3% |
| Q1 2021 | $1,529,000 | +7.3% | 36,678 | +10.0% | 0.23% | -1.3% |
| Q4 2020 | $1,425,000 | -0.4% | 33,357 | -38.7% | 0.23% | -31.3% |
| Q3 2020 | $1,431,000 | -37.3% | 54,452 | -36.0% | 0.34% | -32.9% |
| Q2 2020 | $2,283,000 | -36.4% | 85,144 | -46.4% | 0.50% | +20.2% |
| Q2 2015 | $3,589,000 | +12.0% | 158,947 | -29.2% | 0.42% | +13.5% |
| Q1 2015 | $3,204,000 | – | 224,384 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |